{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:09:35Z","timestamp":1790636975668,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T00:00:00Z","timestamp":1321833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12325-011-0082-5","type":"journal-article","created":{"date-parts":[[2011,11,23]],"date-time":"2011-11-23T07:17:12Z","timestamp":1322032632000},"page":"1105-1113","source":"Crossref","is-referenced-by-count":93,"title":["Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients"],"prefix":"10.1007","volume":"28","author":[{"given":"Giuseppe","family":"Marazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cacciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pelliccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Iaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Volterrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Caminiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sposato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,21]]},"reference":[{"key":"82_CR1","unstructured":"American Heart Association 2011. Heart and Stroke Statistical Update. Available at: http:\/\/www.heart.org\/HEARTORG\/General\/Heart-and-Stroke-Association-Statistics_UCM_319064_SubHomePage.jsp . Last accessed November 7, 2011."},{"key":"82_CR2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","volume":"326","author":"N.J. Wald","year":"2003","unstructured":"Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326: 1419. Erratum in: BMJ. 2003;327:586. BMJ. 2006;60:823.","journal-title":"BMJ"},{"key":"82_CR3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S. Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937\u2013952.","journal-title":"Lancet"},{"key":"82_CR4","first-page":"1829","volume":"70","author":"S. Lewington","year":"2007","unstructured":"Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths Prospective Studies Collaboration Lancet. 2007;70:1829\u20131839.","journal-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths Prospective Studies Collaboration Lancet"},{"key":"82_CR5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archinte.1993.00410090025004","volume":"153","author":"R.A. Kronmal","year":"1993","unstructured":"Kronmal RA, Cain KC, Omenn GS. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med. 1993;153:1065\u20131073.","journal-title":"Arch Intern Med"},{"key":"82_CR6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/01.CIR.0000139312.10076.BA","volume":"110","author":"C.J. Vaughan","year":"2004","unstructured":"Vaughan CJ, Gotto AM Jr. Update on statins: 2003. Circulation. 2004;110:886\u2013892.","journal-title":"Circulation"},{"key":"82_CR7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2007.06.063","volume":"51","author":"J. Afilalo","year":"2008","unstructured":"Afilalo J, Duque G, Steele R, et al. Statins for secondary prevention in elderly patients. J Am Coll Cardiol. 2008;51:37\u201345.","journal-title":"J Am Coll Cardiol"},{"key":"82_CR8","first-page":"1682","volume":"289","author":"P.D. Thompson","year":"2003","unstructured":"Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003;289:1682\u20131690.","journal-title":"JAMA"},{"key":"82_CR9","doi-asserted-by":"crossref","first-page":"69C","DOI":"10.1016\/j.amjcard.2005.12.013","volume":"97","author":"P.D. Thompson","year":"2006","unstructured":"Thompson PD, Clarkson PM, Rosenson RS. National Lipid Association Statin Safety Task Force Muscle Safety Expert Panel. An assessment of statin safety by muscle experts Am J Cardiol. 2006;97:69C\u201376C.","journal-title":"Am J Cardiol"},{"key":"82_CR10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","volume":"288","author":"C.A. Jackevicius","year":"2002","unstructured":"Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462\u2013467.","journal-title":"JAMA"},{"key":"82_CR11","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.CIR.0000012530.68333.C8","volume":"105","author":"C. Heeschen","year":"2002","unstructured":"Heeschen C, Hamm CW, Laufs U, et al. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. Withdrawal of statins increases event rates in patients with acute coronary syndromes. For the Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. Circulation. 2002;105:1446\u20131452.","journal-title":"Circulation"},{"key":"82_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10557-006-6752-x","volume":"20","author":"M.K. Thomas","year":"2006","unstructured":"Thomas MK, Narang D, Lakshmy R, et al. Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients \u2018on\u2019 and \u2018off\u2019 atorvastatin for short time intervals. Cardiovasc Drugs Ther. 2006;20:37\u201344.","journal-title":"Cardiovasc Drugs Ther"},{"key":"82_CR13","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1208\/ps050325","volume":"5","author":"E.K. Kalra","year":"2003","unstructured":"Kalra EK. Nutraceutical \u2014 definition and introduction. AAPS PharmSci. 2003;5:E25.","journal-title":"AAPS PharmSci"},{"key":"82_CR14","first-page":"26","volume":"57","author":"A.F.G. Cicero","year":"2007","unstructured":"Cicero AFG, Rovati L, Setnikar I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents in humans. Arzneimittelforschung. 2007;57:26\u201330.","journal-title":"Arzneimittelforschung"},{"key":"82_CR15","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","volume":"10","author":"W. Kong","year":"2004","unstructured":"Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Med. 2004;10;1344\u20131351.","journal-title":"Nature Med"},{"key":"82_CR16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ajcn\/69.2.231","volume":"69","author":"D. Heber","year":"1999","unstructured":"Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr. 1999;69:231\u2013236.","journal-title":"Am J Clin Nutr"},{"key":"82_CR17","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7326\/0003-4819-150-12-200906160-00006","volume":"150","author":"D.J. Becker","year":"2009","unstructured":"Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med. 2009;150:830\u2013839, W147\u20139.","journal-title":"Ann Intern Med"},{"key":"82_CR18","first-page":"27","volume":"14","author":"P. Pons","year":"1994","unstructured":"Pons P, Rodriguez M, Robaina C, et al. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment. Int J Clin Pharmacol Res. 1994;14:27\u201333.","journal-title":"Int J Clin Pharmacol Res"},{"key":"82_CR19","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1079\/BJN20061715","volume":"95","author":"A. Greyling","year":"2006","unstructured":"Greyling A, De Witt C, Oosthuizen W, et al. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects. Br J Nutr. 2006;95:968\u2013975.","journal-title":"Br J Nutr"},{"key":"82_CR20","first-page":"203","volume":"7","author":"M. Janikula","year":"2002","unstructured":"Janikula M. Policosanol: a new treatment for cardiovascular disease? Altern Med Rev. 2002;7:203\u2013217.","journal-title":"Altern Med Rev"},{"key":"82_CR21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.106.107144","volume":"318","author":"D.K. Singh","year":"2006","unstructured":"Singh DK, Li L, Porter TD. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. J Pharmacol Exp Ther. 2006;318:1020\u20131026.","journal-title":"J Pharmacol Exp Ther"},{"key":"82_CR22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.numecd.2009.05.017","volume":"20","author":"F. Affuso","year":"2010","unstructured":"Affuso F, Ruvolo A, Micillo F, et al. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. Nutr Metab Cardiovasc Dis. 2010;20:656\u2013661.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"82_CR23","first-page":"711","volume":"8707","author":"Y.X. Ni","year":"1988","unstructured":"Ni YX. Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research. Zhong Xi Yi Jie He Za Zhi. 1988;8707:711\u2013713.","journal-title":"Zhong Xi Yi Jie He Za Zhi"},{"key":"82_CR24","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1194\/jlr.M600020-JLR200","volume":"47","author":"J.M. Brusq","year":"2006","unstructured":"Brusq JM, Ancellin N, Grondin P, et al. Inhibition of lipid synthesis through activation of AMPkinase: an additional mechanism for the hypolipidemic effects of Berberine. J Lipid Res. 2006;47:1281\u20131288.","journal-title":"J Lipid Res"},{"key":"82_CR25","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1210\/jc.2007-2404","volume":"93","author":"Y. Zhang","year":"2008","unstructured":"Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocr Metab. 2008;93:2559\u20132565.","journal-title":"J Clin Endocr Metab"},{"key":"82_CR26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1055\/s-2003-41121","volume":"69","author":"G.Y. Pan","year":"2003","unstructured":"Pan GY, Huang ZJ, Wang GJ. The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med. 2003;69:632\u2013636.","journal-title":"Planta Med"},{"key":"82_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.metabol.2008.08.013","volume":"58","author":"W.J. Kong","year":"2009","unstructured":"Kong WJ, Zhang H, Song DQ, et al. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism. 2009;58:109\u2013119.","journal-title":"Metabolism"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-011-0082-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-011-0082-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-011-0082-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T23:48:17Z","timestamp":1560988097000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-011-0082-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,21]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s12325-011-0082-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,21]]}}}